Medicure Inc. (CVE:MPH – Get Free Report)’s share price hit a new 52-week low during trading on Monday . The stock traded as low as C$0.99 and last traded at C$0.99, with a volume of 3300 shares trading hands. The stock had previously closed at C$1.03.
Medicure Stock Down 3.9 %
The company has a market cap of C$10.15 million, a P/E ratio of 11.00 and a beta of 1.01. The company has a debt-to-equity ratio of 2.86, a quick ratio of 1.29 and a current ratio of 2.28. The firm’s 50-day simple moving average is C$1.15 and its 200 day simple moving average is C$1.35.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Recommended Stories
- Five stocks we like better than Medicure
- What does consumer price index measure?
- GE Aerospace is Ready for Liftoff After Strong Earnings
- What Does a Stock Split Mean?
- The Bottom is in For Tesla: Read This Before Buying the Bounce
- What Are Dividend Achievers? An Introduction
- 3 Technologies to Challenge NAND Flash Dominance in AI
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
